✨ Free AI Report
NIOX Group Plc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research NIOX Group Plc
Company Research

NIOX Group Plc: Business Overview, Financials & Competitive Analysis

NIOX Group Plc scores 7/10 on the AskCyborg Cyborg Score (Strong). Focused respiratory diagnostics player with global reach, strong product-market fit, and recent innovation positioning for continued market share expansion. NIOX holds a market-leading position in the specialized FeNO diagnostic space with global distribution in 50+ countries and recent product innovation. However, the company faces typical medtech challenges including regulatory.

What is NIOX Group Plc's industry? NIOX Group Plc (niox.com) operates in Medical Devices - Respiratory Diagnostics. AskCyborg classifies NIOX Group Plc under Medical Devices - Respiratory Diagnostics in its company registry.

NIOX Group is a British medical device manufacturing company focused on products for treating respiratory diseases, producing NIOX (Nitric Oxide) FeNO devices to help diagnose and manage asthma. The NIOX VERO is a non...

7/ 10Strong

Cyborg Score thesis

Focused respiratory diagnostics player with global reach, strong product-market fit, and recent innovation positioning for...

Read the full analyst-debate transcript →
Industry Medical Devices - Respiratory Diagnostics
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest NIOX Group Plc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for NIOX Group Plc

AskCyborg analysts argue the bull and bear cases for NIOX Group Plc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
NIOX Group Plc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

NIOX Group Plc Overview

Pro stress-test →

NIOX Group is a British medical device manufacturing company focused on products for treating respiratory diseases, producing NIOX (Nitric Oxide) FeNO devices to help diagnose and manage asthma. The NIOX VERO is a non-invasive point-of-care system measuring Fractional Exhaled Nitric Oxide (FeNO) levels in patients.

Strategic Profile

Pro stress-test →

NIOX products are available in over 50 countries with local teams and distributor networks providing customer support. The company derives a majority of its revenue from Asia Pacific with presence in the EU, US, UK, and other regions. The company launched the new NIOX PRO in December.

Competitive Landscape

Pro stress-test →

NIOX operates in the specialized respiratory diagnostics market with limited direct competitors in FeNO measurement. Competitive threats include broader respiratory diagnostic platforms and potential new entrants, though NIOX maintains gold-standard positioning. Primary competition exists within asthma management tools and spirometry providers.

Industry Context

NIOX Group Plc operates in Medical Devices - Respiratory Diagnostics.

Key facts

Founded: 2006 · Headquarters: Oxford, UK · Employees: 51-200 · Market cap: £271.66m

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on NIOX Group Plc.

  • Dominant position in FeNO measurement with NIOX VERO and newly launched NIOX PRO representing innovation pipeline
  • Recent product launch and January 2025 trading update suggest positive momentum and renewed investor interest
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • December 2024NIOX PRO successfully launched
  • January 2025Positive trading update released
  • +1 moreTrack every material event for NIOX Group Plc as it happens. Explore monitoring →
Get alerted when NIOX Group Plc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare NIOX Group Plc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

NIOX Group Plc operates in Medical Devices - Respiratory Diagnostics. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Respiratory Diagnostics research →
NEW · MCP server

Ask your AI assistant about NIOX Group Plc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare NIOX Group Plc and its top competitor on Cyborg Score”
“What did NIOX Group Plc do this quarter?”
“Is NIOX Group Plc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does NIOX Group Plc do?+
NIOX Group is a British medical device manufacturing company focused on products for treating respiratory diseases, producing NIOX (Nitric Oxide) FeNO devices to help diagnose and manage asthma. The NIOX VERO is a non...
What is NIOX Group Plc's Cyborg Score?+
NIOX Group Plc has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are NIOX Group Plc's main competitors?+
Named competitors include Spirometry Systems, Comprehensive Respiratory Platforms. The full competitive landscape is in the AskCyborg report.
How can I get the full NIOX Group Plc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the NIOX Group Plc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track NIOX Group Plc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual